AKT1 and prostate cancer: According to the KEGG pathway analysis, the selected network may include the PI3K-Akt signalling route and the Prostate cancer signalling pathway, both of which lend credence to the idea that the polyherbal formulation could be useful in the treatment of prostate cancer.